Zomedica Pharmaceuticals Corp.

100 Phoenix Drive, Suite 180

Ann Arbor, Michigan 48108

May 20, 2020

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re:	Zomedica Pharmaceuticals Corp. (the “Company”)
	Registration Statement on Form S-1, as amended (File No. 333-238322)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 9:00 a.m., Eastern Time, on May 26, 2020, or as soon as practicable thereafter.

Please call John D. Hogoboom of Lowenstein Sandler LLP at (973) 597-2382 to confirm the effectiveness of the Registration Statement or with any questions.

[Signature page follows.]

U.S. Securities and Exchange Commission

May 20, 2020

Page 2

Very truly yours,
ZOMEDICA PHARMACEUTICALS CORP.
By:	/s/ Shameze Rampertab
Name:	Shameze Rampertab
Title:	Interim Executive Officer and Chief Financial Officer

- 2 -